Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Ximan Hongtu Information Technology is a Chinese pharmaceutical intermediate and active pharmaceutical ingredient (API) supplier that provides integrated cross-border supply and technical solutions. Established in 2015, the company specializes in high-value intermediates for therapeutic areas including oncology, cardiovascular health, and neurology. Beyond product distribution, the company offers end-to-end technical support such as process optimization, green synthesis pathway consulting, and biocatalysis technology transfer. Xi'an Ximan Hongtu serves a global network of over 280 clients across 60 countries and maintains compliance with international regulatory standards including ISO 9001 and GMP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Ximan Hongtu Information Technology.